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The research and views presented in this special edition of Transactions of the 
Royal Society of Hygiene and Tropical 
 
Medicine take us to the human–animal interface, where human exposure to 
zoonotic and vector-borne diseases occurs. From mobile pastoralism in the 
Sahel1 and small-scale farming in Vietnam2 to hospital stays in South Korea,3 a 
wide range of interactions with varied ecologies and pathogens is described. 
Where standard data sources and methodologies fall short, the authors have 
consulted sources such as news media reports.4 While some of the authors 
consider relatively recent infectious disease emergence, like Middle East 
Respiratory Syndrome,3 others examine longer-standing public health risks. 
These include schistosomiasis,1,5 which continues to exact a large burden in 
sub-Saharan Africa despite affordable and effective prophylaxis and treatment 
options, in part because infected livestock are kept near human water sources. 
Still other contributions examine global efforts to combat emerging antimicrobial 
resistance (AMR). While the use of antimicrobials in humans and animals helps 
drive AMR, there is not necessarily a simple causal relationship between AMR in 
food animals and people, as commonly thought. Kahn describes more cryptic 
pathways and linkages that are emerging and not monitored, such as through the 
open defecation of billions of humans and domestic or feral animals like the dog, 
which regularly receive antibiotics and which may seed the environment with 
resistant bacteria.6 Given this spectrum of zoonotic and infectious disease 
threats, both national and global solutions are required across many sectors 
including human health, agriculture and the environment. National systems must 
be robust enough to detect, assess risks and respond rapidly to major changes in 
risk; and to address known risk factors that threaten people every day, especially 
the most vulnerable populations, in order to prevent infection. A paradigm shift in 
our understanding of the drivers of emerging diseases is shifting focus  
from reaction and reliance on technical and pharmaceutical solutions to 
promoting structural changes in our society, health systems and the approach to 
environment and development. A principal change arises from the knowledge 
that resilience in ecosystems—whether in the intestine of humans or the global 
landscape—has a stabilizing effect on pathogen behavior. This is illustrated in 
the Ross River and Murray Valley in Western Australia, where the risk of 
infection appears to shift with both natural climatic patterns and human-made 
environmental manipulations; and for which Mackenzie and colleagues describe 
a robust architecture of monitoring climate, animal and vector populations, water 
sources and other ecological factors determining human risk in order to prevent 
outbreaks.7 The shift away from viewing the host and pathogen in isolation, to 
understanding the crucible in which they live, increases complexity and requires 
a more integrative scientific method that we now refer to as One Health. In this 
context, Machalaba and colleagues report on an interdisciplinary collaboration 
investigating how best to evaluate the economic value of investing in One Health 
approaches to better control and prevent zoonotic infections. On the same 
theme, Phelan and Gostin discuss how global-level legal strategies for tackling 
antimicrobial resistance, such as global regulations or a treaty, could strengthen 
multisectoral, multi-institutional collaboration on infectious disease, with important 
benefits for pandemic preparedness at the global level.8 Canavan and 
colleagues point out that managing infectious disease risk in the food system, 
without considering other sectors, such as nutrition and sustainability, appears an 
ineffective and inefficient strategy for preventing infectious disease outbreaks; 
they argue for an integrated approach instead.9 
Recent pandemic threats like Ebola and Zika viruses have spurred a global 
conversation around resilience in health systems. Their ability to react and 
rebound when dangers arise.10 The contributions to this special issue illustrate a 
One Health approach to the risk assessment of and response to infectious 
diseases, emphasizing connections among human health, animal health and the 
environment. This strategy is essential to infectious disease resilience writ large, 
and resilience of health systems in particular. In addition to organizing systems 
for rapid detection and response, the broader One Health view urges us to 
rethink prevention. In particular, we should reject an economic paradigm 
exclusively focused on production or economic development at any cost, 
especially in areas like agriculture, where emerging zoonotic disease risk is 
significant. 
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